Lymphangiogenesis induced by vascular endothelial growth factor receptor 1 signaling contributes to the progression of endometriosis in mice.

[1]  M. Shibuya,et al.  The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  M. Shibuya,et al.  VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues , 2019, Scientific Reports.

[3]  M. Shibuya,et al.  Vascular endothelial growth factor receptor 1 tyrosine kinase signaling facilitates healing of DSS-induced colitis by accumulation of Tregs in ulcer area. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  S. Akira,et al.  Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. , 2018, Journal of hepatology.

[5]  K. Tsujikawa,et al.  RAMP1 in Kupffer cells is a critical regulator in immune-mediated hepatitis , 2018, bioRxiv.

[6]  M. Shibuya,et al.  Vascular endothelial growth factor receptor 1 (VEGFR1) tyrosine kinase signaling facilitates granulation tissue formation with recruitment of VEGFR1+ cells from bone marrow , 2018, Anatomical Science International.

[7]  K. Tsujikawa,et al.  RAMP1 signaling improves lymphedema and promotes lymphangiogenesis in mice. , 2017, The Journal of surgical research.

[8]  T. Kawakami,et al.  Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice , 2016, PloS one.

[9]  M. Shibuya,et al.  Vascular Endothelial Growth Factor Receptor Type 1 Signaling Prevents Delayed Wound Healing in Diabetes by Attenuating the Production of IL-1β by Recruited Macrophages. , 2016, The American journal of pathology.

[10]  M. Shibuya,et al.  Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model , 2016 .

[11]  Bruce A. Corliss,et al.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis , 2016, Microcirculation.

[12]  M. Shibuya,et al.  The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia , 2015, PloS one.

[13]  A. Hey-Cunningham,et al.  The Role of the Lymphatic System in Endometriosis: A Comprehensive Review of the Literature1 , 2015, Biology of reproduction.

[14]  C. Calhaz-Jorge,et al.  Angiogenesis as a therapeutic target in endometriosis. , 2014, Acta medica portuguesa.

[15]  A. Fassbender,et al.  A novel mouse model of endometriosis mimics human phenotype and reveals insights into the inflammatory contribution of shed endometrium. , 2014, The American journal of pathology.

[16]  K. Tsujikawa,et al.  Roles of receptor activity‐modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  M. Shibuya,et al.  Vascular endothelial growth factor receptor 1 signaling facilitates gastric ulcer healing and angiogenesis through the upregulation of epidermal growth factor expression on VEGFR1+CXCR4+ cells recruited from bone marrow , 2014, Journal of Gastroenterology.

[18]  M. Menger,et al.  Anti-angiogenic treatment strategies for the therapy of endometriosis. , 2012, Human reproduction update.

[19]  E. Gordon,et al.  Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis , 2012, Vascular cell.

[20]  A. Schneider,et al.  High Lymph Vessel Density and Expression of Lymphatic Growth Factors in Peritoneal Endometriosis , 2012, Reproductive Sciences.

[21]  Antonio Duarte,et al.  Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF–VEGFR2 signalling , 2012, Nature.

[22]  K. Alitalo,et al.  The lymphatic vasculature in disease , 2011, Nature Medicine.

[23]  C. Köhler,et al.  Lymphangiogenesis in deep infiltrating endometriosis. , 2011, Human reproduction.

[24]  K. Alitalo,et al.  Roles of Prostaglandin E2–EP3/EP4 Receptor Signaling in the Enhancement of Lymphangiogenesis During Fibroblast Growth Factor-2–Induced Granulation Formation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[25]  I. Fraser,et al.  Lymphatic Vessels in Peritoneal Endometriotic Lesions , 2011 .

[26]  S. Akira,et al.  The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  S. Narumiya,et al.  Tumorigenesis and Neoplastic Progression COX-2 and Prostaglandin EP 3 / EP 4 Signaling Regulate the Tumor Stromal Proangiogenic Microenvironment via CXCL 12-CXCR 4 Chemokine Systems , 2010 .

[28]  Kjetil Boye,et al.  S100A4 and metastasis: a small actor playing many roles. , 2010, The American journal of pathology.

[29]  Kenji Sunagawa,et al.  Soluble Flt-1 Gene Transfer Ameliorates Neointima Formation After Wire Injury in flt-1 Tyrosine Kinase–Deficient Mice , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[30]  M. Shibuya.  Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis. , 2008, BMB reports.

[31]  Y. Hung,et al.  Vascular endothelial growth factor A and C gene expression in endometriosis. , 2004, Human pathology.

[32]  T. Noda,et al.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[34]  M. Waer,et al.  Immunohistochemical characterization of leucocyte subpopulations in endometriotic lesions , 1993, Archives of Gynecology and Obstetrics.